Serum levels of soluble IL-2 receptor, soluble ICAM-1, TNF-alpha, interleukin-4 and interleukin-6 in scleroderma

Journal of the European Academy of Dermatology and Venereology

Volumn 8, Issue 3, 1997, Pages 222-228

  Bruns, M ^a   Haustein, U F ^a   Hofmann, Ch ^a   Herrmann, K ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Interleukin 4; Interleukin 6; Soluble ICAM 1; Soluble IL 2 receptor; Systemic scleroderma; Tumour necrosis factor alpha

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; SKIN INFLAMMATION; SYSTEMIC SCLEROSIS;

EID: 0030803853     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0926-9959(97)00610-7     Document Type: Article

References (23)

1. Hirano TS, Akira T, Taga I. Biological and clinical aspects of Interleukin-6. Immunol Today 1990; 11:443-449.
2. Maquart FX, Gillery P, Kalis B, Borel J-P. Cytokines and fibrosis. Eur J Dermatol 1994;4:91-97.
3. Lewis DB, Prickett KS, Larsen A et al. Restricted production of interleukin-4 by activated human T cells. Proc Natl Acad Sci USA 1990;85:9743-9747.
4. Sfikakis PP, Tesar J, Baraf H et al. Circulating intercellular adhesion molecule-1 in patients with systemic sclerosis. Clin Immunol Immunopathol 1993;68:88-92.
5. Kroemer G, Wick G. The role of interleukin-2 in autoimmunity. Immunol Today 1989;10:246-251.
6. Rubin LA, Nelson DL. The soluble interleukin-2 receptor: biology, function, and clinical application. Ann Intern Med 1990;113:619-627.
7. Degiannis D, Seibold JR, Czarnecki M. et al.; Soluble interleukin-2 receptors in patients with systemic sclerosis. Clinical and laboratory correlations. Arthritis Rheum 1990;33:375-380.
8. Krieg T, Meurer M. Systemic scleroderma. Clinical and pathophysiologic aspects. J Am Acad Dermatol 1988;18:457-484.
9. Massobrio R, Lisa F, Novelli M, Bernengo MG. Serum levels of soluble receptors of interleukin-2 in skin pathology. G Ital Dermatol Venereol 1990; 125:1-6.
10. Clements PJ, Peter JB, Agopian MS et al. Elevated serum levels of soluble interleukin 2 receptor, interleukin 2 and neopterin in diffuse and limited scleroderma: effects of chlorambucil. J Rheumatol 1990;17:908-910.
11. Airo P, Bettinzioli M, Gorla R, Cattaneo R. Increased concentrations of soluble interleukin-2 receptor in the serum of patients with systemic sclerosis [letter]. Ann Rheum Dis 1991;50:270-271.
12. Kahaleh MB. Soluble immunologic products in scleroderma sera. Clin Immunol Immunopathol 1991;58:139-144.
13. Bruns M, Herrmann K, Haustein UF. Immunologic parameters in systemic sclerosis. Int J Dermatol 1994;33:25-32.
14. Needleman BW. Increased expression of intercellular adhesion molecule 1 on the fibroblasts of scleroderma patients. Arthritis Rheum 1990:33:1847-1851.
15. Sollberg S, Peltonen J, Uitto J, Jimenez SA. Elevated expression of beta 1 and beta 2 integrins, intercellular adhesion molecule 1, and endothelial leukocyte adhesion molecule 1 in the skin of patients with systemic sclerosis of recent onset. Arthritis Rheum 1992;35:290-298.
16. Kantor TV, Friberg D, Medsger Jr. TA et al. Cytokine production and serum levels in systemic sclerosis. Clin Immunol Immunopathol 1992;65:278-285.
17. Needleman BW, Wigley FM, Stair RW. Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor alpha, and interferon-gamma levels in sera from patients with scleroderma. Arthritis Rheum 1992:35:67-72.
18. Takeda K, Hatamochi A, Arakawa M, Ueki H. Effects of tumor necrosis factor-alpha on connective tissue metabolism in normal and scleroderma fibroblast cultures. Arch Dermatol Res 1993;284:440-444.
19. Mauviel A, Heino J, Kähäri VM et al. Comparative effects of interleukin-1 and tumor necrosis factor-alpha on collagen production and corresponding procollagen mRNA levels in human dermal fibroblasts. J Invest Dermatol 1991;96:243-249.
20. Feghali CA, Bost KL, Boulware DW, Levy LS. Mechanisms of pathogenesis in scleroderma. 1. Overproduction of interleukin 6 by fibroblasts cultured from affected skin sites of patients with scleroderma. J Rheumatol 1992; 19:1207-1211.
21. Smith EA. Connective tissue metabolism including cytokines in scleroderma. Curr Opin Rheumatol 1992;4:869-877.
22. Fertin C, Nicolas JF, Gillery P et al. Interleukin-4 stimulates collagen synthesis by normal and scleroderma fibroblasts in dermal equivalents. Cell Mol Biol 1991;37:823-829.
23. Famularo G, Procopio A, Giacomelli R et al. Soluble interleukin-2 receptor, interleukin-2 and interleukin-4 in sera and supernatants from patients with progressive systemic sclerosis. Clin Exp Immunol 1990;81:368-372.